Corcept Therapeutics Incorporated
$113.88
-3.05 (-2.61%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -3.8%
- 3 Months
- +63.9%
- YTD
- +227.2%
- 1 Year
- +63.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 82.2%
- Largest decline max drawdown, since Aug 2025
- -64.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.09
Own CORT?
See how CORT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.